:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Author:	Glaucio, Ferreira
Format:	Recurso digital
Language:
Published:	Zenodo 2026
Online Access:	https://doi.org/10.5281/zenodo.19352382
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Synthesis, in vitro and in silico evaluation of gallamide and selenogallamide derivatives as inhibitors of the SARS‐CoV‐2 main protease
by: Maryelle A. G. de Carvalho, et al.
Published: (2024)

Psoralidin acts as a dual protease inhibitor against PL pro and M pro of SARS ‐ CoV ‐2
by: Aditya Trivedi, et al.
Published: (2025)

An exhaustive computational bioassessment of plant‐derived terpenoids as potential SARS‐CoV‐2 inhibitors
by: Arunkumar Radhakrishnan, et al.
Published: (2026)

Pharmacological reprogramming of plitidepsin as a SARS-CoV-2 inhibitor.
by: Jimeno, Jose, et al.
Published: (2025)

Phthalimide derivatives as a new class of papain‐like protease inhibitors in SARS‐CoV‐2
by: Thomas Fischer, et al.
Published: (2024)

Involvement of SARS‐CoV‐2 accessory proteins in immunopathogenesis
by: Hayato Ito, et al.
Published: (2024)

Safety and immunogenicity of vaccines against SARS-CoV-2
by: Francisco Xavier Poveda Paredes
Published: (2021)

Nanomechanical collective vibration of SARS‐CoV‐2 spike proteins
by: Changfeng Cao, et al.
Published: (2024)

Studies on the synthesis of sugar chalcone derivatives for protein binding
by: Arasappan Hemamalini, et al.
Published: (2024)

Humoral epitope dominance and immune imprinting by SARS ‐ CoV ‐1 and SARS ‐ CoV ‐2 vaccines
by: Deborah L Burnett, et al.
Published: (2026)

SARS-CoV-2 and Saliva: an update
by: Muniz, Isis de Araújo Ferreira, et al.
Published: (2020)

Coronavirus (SARS-CoV-2): Preventions, keys to diagnosis and treatment of SARS-CoV-2
by: Kuldeep Singh Patel
Published: (2020)

Antibody‐dependent enhancement (ADE) of SARS‐CoV‐2 in patients exposed to MERS‐CoV and SARS‐CoV‐2 antigens
by: Swapna Thomas, et al.
Published: (2024)

Books and arts. Do you sincerely want to go crazy?
Published: (2002)

Structure-based screening of marine carotenoids: fucoxanthin and its derivatives as potential inhibitors of the SARS-CoV-2 nucleocapsid phosphoprotein.
by: Paidi, Murali Krishna, et al.
Published: (2026)

Research progress in Fc‐effector functions against SARS‐CoV‐2
by: Rongyuan Gao, et al.
Published: (2024)

Ensemble docking based virtual screening of SARS‐CoV‐2 main protease inhibitors
by: Anastasia D. Fomina, et al.
Published: (2024)

Correlation analysis of the dispersion of SARS-CoV-2 in Mexico
by: López, Pablo Carlos, et al.
Published: (2026)

A peptide derived from SARS‐CoV‐2 nucleocapsid protein with broad‐spectrum anti‐coronavirus activity
by: Guoguo Ye, et al.
Published: (2024)

Torsional twist of the SARS ‐ CoV and SARS ‐ CoV ‐2 SUD ‐N and SUD ‐M domains
by: Monica Rosas‐Lemus, et al.
Published: (2025)

Coagulation modifiers targeting SARS-CoV-2 main protease Mpro for COVID-19 treatment: an in silico approach
by: Biembengut, Ísis Venturi, et al.
Published: (2020)

Pandemia por SARS-CoV-2
by: Erina Petrera
Published: (2020)

Structural Immunology of SARS‐CoV‐2
by: Meng Yuan, et al.
Published: (2024)

Demografía y SARS-CoV-2
by: Manuel Ordorica Mellado
Published: (2021)

Antiviral efficacy of heparan sulfate and enoxaparin sodium against SARS‐CoV‐2
by: Virginia Fuochi, et al.
Published: (2024)

Optimization of a DNA‐launched SARS‐CoV‐2 replicon with RNA splicing inhibitor Isoginkgetin
by: Hu Zhang, et al.
Published: (2024)

Phylogeography of horseshoe bat sarbecoviruses in Vietnam and neighbouring countries. Implications for the origins of SARS ‐ CoV and SARS ‐ CoV ‐2
by: Alexandre Hassanin, et al.
Published: (2024)

SARS-CoV-2 and ACE2 nexus
by: Arifuddin, Mehnaaz Sameera
Published: (2020)

SARS ‐ CoV ‐2 nucleocapsid protein variants have differential RNA chaperone activity
by: Sabrina Babl, et al.
Published: (2025)

Exploring essential oils as prospective therapy against the ravaging Coronavirus (SARS-CoV-2)
by: Emmanuel Onah Ojah
Published: (2020)

Short‐lived neutralizing activity against SARS‐CoV‐2 in newborns of immunized mothers
by: Marta Stracuzzi, et al.
Published: (2025)

Spumigins produced by Nodularia spumigena are natural serine protease inhibitors with anti-SARS-CoV-2 activity.
by: Milewska, Aleksandra, et al.
Published: (2026)

Capillary electrokinetic chromatography for chiral separation of potential SARS‐CoV‐2 3CL protease inhibitors
by: Lucile Brier, et al.
Published: (2024)

Improved fluorescence‐based assay for rapid screening and evaluation of SARS‐CoV‐2 main protease inhibitors
by: Rui Zhang, et al.
Published: (2024)

SARS-CoV-2 y aparato digestivo
by: Iván Carabaño Aguado
Published: (2020)

SARS-CoV-2: a clinical update
by: da Silveira Cespedes, Mateus, et al.
Published: (2020)

COVID-19 y SARS-CoV-2
by: Alfredo Pinzón-Junca
Published: (2020)

HAX1 mediates SARS ‐ CoV ‐2 spike‐triggered unfolded protein response in host cells
by: Fang Zhu, et al.
Published: (2025)

Non‐Neutralising Antibodies and T Cell Responses to SARS ‐ CoV ‐2 Detected in Unvaccinated SARS ‐ CoV ‐2‐Naive Spanish Adolescents
by: Hector F. Pelaez‐Prestel, et al.
Published: (2025)

SARS‐CoV‐2 nucleocapsid antigen in plasma of children hospitalized for COVID‐19 or with incidental detection of SARS‐CoV‐2 infection
by: Nicolas Capelli, et al.
Published: (2024)